Storage and use of residual newborn screening blood spots: a public policy emergency
- PMID: 21673578
- PMCID: PMC3607938
- DOI: 10.1097/GIM.0b013e31822176df
Storage and use of residual newborn screening blood spots: a public policy emergency
Comment on
-
Committee report: Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening.Genet Med. 2011 Jul;13(7):621-4. doi: 10.1097/GIM.0b013e3182147639. Genet Med. 2011. PMID: 21602691
References
-
- Health Resources and Services Administration [Accessed April 22, 2011];Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children. 2011 Available at: http://www.hrsa.gov/heritabledisorderscommittee/
-
- Therrel BL, Jr, Hannon WH, Bailey DB, Jr, Goldman EB, Monaco J, Norgaard-Pedersen B, et al. Committee report: considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening. Genet Med. 2011;13:621–624. - PubMed
-
- Olney RS, Moore CA, Ojodu JA, Lindegren ML, Hannon WH. Storage and use of residual dried blood spots from state newborn screening programs. J Pediatr. 2006;148:618–622. - PubMed
-
- Spliethoff HM, Tao L, Shaver SM, et al. Use of newborn screening program blood spots for exposure assessment: declining levels of perluorinated compounds in New York State infants. Environ Sci Technol. 2008;42:5361–5367. - PubMed
